Valeant Pharmaceuticals (VRX): Q2 EPS of $1.01 beats by $0.02. Revenue of $820.1M (+34.6% Y/Y)...

|About: Valeant Pharmaceuticals ... (VRX)|By:, SA News Editor
Valeant Pharmaceuticals (VRX): Q2 EPS of $1.01 beats by $0.02. Revenue of $820.1M (+34.6% Y/Y) misses by $2.6M. (PR)